SVTR 硅谷科技评论SVTR
← Database
ApplicationsLife Sciences
Total funding $4M📍 Stockholm · Northern EuropeFounded 2015

About

Corsmed, founded in 2015 in Stockholm, Sweden, develops advanced MRI simulation software for medical training and diagnostics.

★ SVTR RatingSVTR has evaluated this company

Full tier & rationale — an SVTR Intelligence benefit

Capital graph

CompanyInvestorFounders / teamCo-investment (thicker arc = more shared deals, ×N marks the count)Bigger circle = stronger signal (activity / coverage / interest) · ⛶ fullscreen · scroll / pinch to zoom · hover to highlight · drag nodes · click a node to open its profile

Funding history

Comparable companies· by market

This company

  • Corsmed

    Advanced MRI simulation software for medical training and diagnosis

    Seed · $4M · 2024-12

Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.

Investors that may fit

General Catalyst

40 Life Sciences deals in the last 24 months · 19 at a nearby stage · 2 in Northern Europe

Request intro →

Lightspeed

17 Life Sciences deals in the last 24 months · 5 at a nearby stage · 2 in Northern Europe

Request intro →

LifeX Ventures

8 Life Sciences deals in the last 24 months · 5 at a nearby stage · 1 in Northern Europe

Request intro →

Amino Collective

6 Life Sciences deals in the last 24 months · 5 at a nearby stage · 2 in Northern Europe

Request intro →

Kinnevik

6 Life Sciences deals in the last 24 months · 1 at a nearby stage · 2 in Northern Europe

Request intro →

Calm/Storm Ventures

4 Life Sciences deals in the last 24 months · 4 at a nearby stage · 1 in Northern Europe

Request intro →

Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.

Want to reach Corsmed — for capital, customers, or partnership? Send a short request; SVTR reviews it and brokers the intro, with both sides verified before you meet.

Request an intro to this companySubscribe to Signal